Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Assets (2023 - 2026)

Adagio Medical Holdings has reported Assets over the past 4 years, most recently at $39.3 million for Q1 2026.

  • Quarterly Assets fell 4.91% to $39.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $39.3 million through Mar 2026, down 4.91% year-over-year, with the annual reading at $43.3 million for FY2025, 10.72% down from the prior year.
  • Assets was $39.3 million for Q1 2026 at Adagio Medical Holdings, down from $43.3 million in the prior quarter.
  • Over five years, Assets peaked at $107.2 million in Q3 2024 and troughed at $6.8 million in Q4 2023.
  • The 4-year median for Assets is $40.3 million (2025), against an average of $44.2 million.
  • Year-over-year, Assets surged 609.86% in 2024 and then plummeted 70.57% in 2025.
  • A 4-year view of Assets shows it stood at $6.8 million in 2023, then surged by 609.86% to $48.4 million in 2024, then fell by 10.72% to $43.3 million in 2025, then dropped by 9.12% to $39.3 million in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Assets are $39.3 million (Q1 2026), $43.3 million (Q4 2025), and $31.5 million (Q3 2025).